Detalhe da pesquisa
1.
Residual Humoral Immunity Sustained Over Decades in a Cohort of Vaccinia-Vaccinated Individuals.
J Infect Dis
; 227(8): 1002-1006, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200239
2.
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.
PLoS One
; 16(6): e0253487, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161386
3.
Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.
Virol J
; 5: 80, 2008 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18616831
4.
Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
Virol J
; 5: 130, 2008 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957074
5.
Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.
PLoS One
; 8(10): e76571, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24204639